Review decisions

Showing 240 results of 291 total
Summary Safety Review - Cisplatin - Assessing the Potential Risk of Blood Clots in the Veins (venous thromboembolism)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00087
Issued / Original Publication Date: 2016-02-12
Summary Safety Review - GALEXOS (simeprevir) - Assessing the Potential Risk of Severe Liver Problems
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00001
Issued / Original Publication Date: 2016-01-27
Summary Safety Review - Oral FLUOROQUINOLONES - Assessing the Potential Risk of Retinal Detachment
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00002
Issued / Original Publication Date: 2016-01-08
Summary Safety Review - AVONEX (interferon beta-1a) - Assessing the Potential Risk of Kidney Damage (nephrotic syndrome)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00003
Issued / Original Publication Date: 2015-12-23
Summary Safety Review - Finasteride - Assessing the Potential Risk of Suicidal Thoughts and Behaviour (Suicidality)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00004
Issued / Original Publication Date: 2015-12-17
Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00005
Issued / Original Publication Date: 2015-12-11
Summary Safety Review - Over-the-counter topical acne products containing either BENZOYL PEROXIDE or SALICYLIC ACID - Assessing the potential risk of serious allergic reactions (serious hypersensitivity reactions)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00006
Issued / Original Publication Date: 2015-12-10
Summary Safety Review - CODEINE PRESCRIPTION PRODUCTS Indicated for Cough - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00007
Issued / Original Publication Date: 2015-12-09
Summary Safety Review - GARDASIL (Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) - Assessing General Safety with a Focus on Autoimmune and Cardiovascular Diseases
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00008
Issued / Original Publication Date: 2015-12-09
Summary Safety Review - VOTRIENT (pazopanib) - Assessing the Potential Risk of Accumulation of Fluid Around the Heart (Pericardial Effusion)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00009
Issued / Original Publication Date: 2015-11-30

Displaying 231 - 240 of 291 | Page 24 of 30
Report a problem or mistake on this page
Please select all that apply:
Date modified: